Requirements for a successful future of probiotics

Advances in Probiotic Technology

Volumn , Issue , 2015, Pages 139-145

  Gabriele, Hörmannsperger ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85043602701     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (28)

1. Besselink, M.G., H.C. van Santvoort, E. Buskens, M.A. Boermeester, H. van Goor, H.M. Timmerman, V.B. Nieuwenhuijs, T.L. Bollen, B. van Ramshorst, B.J. Witteman, C. Rosman, R.J. Ploeg, M.A. Brink, A.F. Schaapherder, C.H. Dejong, P.J. Wahab, C.J. van Laarhoven, E. van der Harst, C.H. van Eijck, M.A. Cuesta, L.M. Akkermans, H.G. Gooszen; Dutch Acute Pancreatitis Study Group. 2008. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371: 651-9.
2. Clemente, J.C., L.K. Ursell, L.W. Parfrey and R. Knight. 2012. The impact of the gut microbiota on human health: an integrative view. Cell 148: 1258-70.
3. Corr, S.C., Y. Li, C.U. Riedel, P.W. O'Toole, C. Hill and C.G. Gahan. 2007. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. USA 104: 7617-21.
4. FAO/WHO guidelines, http://www.who.int/foodsafety/fsmanagement/en/probiotic_guidelines.pdf.
5. Flint, H.J., K.P. Scott, P. Louis and S.H. Duncan. 2012. The role of the gut microbiota in nutrition and health. Nature reviews Gastroenterology & Hepatology 9: 577-89.
6. Fukuda, S., H. Toh, K. Hase, K. Oshima, Y. Nakanishi, K. Yoshimura, T. Tobe, J.M. Clarke, D.L. Topping, T. Suzuki, T.D. Taylor, K. Itoh, J. Kikuchi, H. Morita, M. Hattori and H. Ohno. 2011. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469: 543-7.
7. Greenhill, C. 2013. Paediatrics: Differences in the faecal microbiota of children with beta-cell autoimmunity. Nature reviews Endocrinology.
8. Huttenhower, C. and D. Gevers. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486: 207-14.
9. Jijon, H., J. Backer, H. Diaz, H. Yeung, D. Thiel, C. McKaigney, C. De Simone and K. Madsen. 2004. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 126: 1358-73.
10. Kruis, W., P. Fric, J. Pokrotnieks, M. Lukás, B. Fixa, M. Kascák, M.A. Kamm, J. Weismueller, C. Beglinger, M. Stolte, C. Wolff and J. Schulze. 2004. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53: 1617-23.
11. Kwon, H.K., C.G. Lee, J.S. So, C.S. Chae, J.S. Hwang, A. Sahoo, J.H. Nam, J.H. Rhee, K.C. Hwang and S.H. Im. 2010. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc. Natl. Acad. Sci. USA 107: 2159-64.
12. Ly, N.P., A. Litonjua, D.R. Gold and J.C. Celedon. 2011. Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? The Journal of Allergy and Clinical Immunology 127: 1087-94; quiz 95-6.
13. Mimura, T., F. Rizello, U. Helwig, G. Poggioli, S. Schreiber, I.C. Talbot, R.J. Nicholls, P. Gionchetti, M. Campieri and M.A. Kamm. 2004. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53: 108-14.
14. Qin, J., Y. Li, Z. Cai, S. Li, J. Zhu, F. Zhang, S. Liang, W. Zhang, Y. Guan, D. Shen, Y. Peng, D. Zhang, Z. Jie, W. Wu, Y. Qin, W. Xue, J. Li, L. Han, D. Lu, P. Wu, Y. Dai, X. Sun, Z. Li, A. Tang, S. Zhong, X. Li, W. Chen, R. Xu, M. Wang, Q. Feng, M. Gong, J. Yu, Y. Zhang, M. Zhang, T. Hansen, G. Sanchez, J. Raes, G. Falony, S. Okuda, M. Almeida, E. LeChatelier, P. Renault, N. Pons, J.M. Batto, Z. Zhang, H. Chen, R. Yang, W. Zheng, S. Li, H. Yang, J. Wang, S.D. Ehrlich, R. Nielsen, O. Pedersen, K. Kristiansen and J. Wang. 2012. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490: 55-60.
15. Qin, J., R. Li, J. Raes, M. Arumugam, K.S. Burgdorf, C. Manichanh, T. Nielsen, N. Pons, F. Levenez, T. Yamada, D.R. Mende, J. Li, J. Xu, S. Li, D. Li, J. Cao, B. Wang, H. Liang, H. Zheng, Y. Xie, J. Tap, P. Lepage, M. Bertalan, J.M. Batto, T. Hansen, D. Le Paslier, A. Linneberg, H.B. Nielsen, E. Pelletier, P. Renault, T. Sicheritz-Ponten, K. Turner, H. Zhu, C. Yu, S. Li, M. Jian, Y. Zhou, Y. Li, X. Zhang, S. Li, N. Qin, H. Yang, J. Wang, S. Brunak, J. Doré, F. Guarner, K. Kristiansen, O. Pedersen, J. Parkhill, J. Weissenbach, MetaHIT Consortium, P. Bork, S.D. Ehrlich and J. Wang. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65.
16. Round, J.L. and S.K. Mazmanian. 2010. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. USA 107: 12204-9.
17. Sanders, M.E., L.M. Akkermans, D. Haller, C. Hammerman, J. Heimbach, G. Hormannsperger et al. 2010. Safety assessment of probiotics for human use. Gut Microbes 1: 164-85.
18. Shen, Y., M.L. Torchia, G.W. Lawson, C.L. Karp, J.D. Ashwell and S.K. Mazmanian. 2012. Outer membrane vesicles of a human commensal mediate immune regulation and disease protection. Cell Host & Microbe 12: 509-20.
19. Sokol, H., B. Pigneur, L. Watterlot, O. Lakhdari, L.G. Bermudez-Humaran, J.J. Gratadoux, S. Blugeon, C. Bridonneau, J.P. Furet, G. Corthier, C. Grangette, N. Vasquez, P. Pochart, G. Trugnan, G. Thomas, H.M. Blottière, J. Doré, P. Marteau, P. Seksik and P. Langella. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA 105: 16731-6.
20. Szajewska, H., M. Wanke and B. Patro. 2011. Meta-analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children. Aliment Pharm. Ther. 34: 1079-87.
21. Thompson, G.R. and P.C. Trexler. 1971. Gastrointestinal structure and function in germ-free or gnotobiotic animals. Gut 12: 230-5.
22. Tsilingiri, K. and M. Rescigno. 2012. Postbiotics: what else? Beneficial Microbes 69-75.
23. Tursi, A., G. Brandimarte, A. Papa, A. Giglio, W. Elisei, G.M. Giorgetti et al. 2010. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am. J. Gastroenterol. 105: 2218-27.
24. Van Huynegem, K. and L. Steidler. 2012. Clinical development of lactocepin: a novel bacterial biologic? Expert review of Clinical Immunology 8: 597-9.
25. von Schillde, M.A., G. Hormannsperger, M. Weiher, C.A. Alpert, H. Hahne, C. Bauerl, K. van Huynegem, L. Steidler, T. Hrncir, G. Pérez-Martínez, B. Kuster and D. Haller. 2012. Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell Host & Microbe 11: 387-96.
26. Walter, J. 2008. Ecological role of lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research. Appl. Environ. Microbiol. 74: 4985-96.
27. Wostmann, B.S., C. Larkin, A. Moriarty and E. Bruckner-Kardoss. 1983. Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. Laboratory Animal Science 33: 46-50.
28. Yan, F., H. Cao, T.L. Cover, M.K. Washington, Y. Shi and L. Liu. 2011. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J. Clin. Invest. 121: 2242-53.